111 Inc Cash Flow Conversion Efficiency
111 Inc cash flow conversion efficiency. Based on the latest financial reports, 111 Inc (YI) has a cash flow conversion efficiency ratio of -3.363x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-91.72 Million) by net assets ($27.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of 111 Inc (2016–2025)
Cash flow conversion efficiency of 111 Inc from 2016 to 2025. This chart illustrates how 111 Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest 111 Inc stock price today for real-time trading data and today's change.
111 Inc Cash Flow Conversion Ratio Explained
111 Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
111 Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of 111 Inc ranked by their cash flow conversion efficiency. Also see 111 Inc stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Interwood-Xylemporia A.T.E.N.E.
AT:XYLEK
|
0.043x |
|
Critical Resources Ltd
AU:CRR
|
-0.030x |
|
Salee Printing Public Company Limited
BK:SLP
|
0.023x |
|
Saranacentral Bajatama Tbk
JK:BAJA
|
0.636x |
|
Posco C&C Stl
KO:058430
|
0.033x |
|
SenzaGen AB
ST:SENZA
|
-0.052x |
|
Immo Mcc NV
BR:MCC
|
N/A |
|
VIRINCHI ORD (BSE)
NSE:VIRINCHI
|
0.014x |
Annual Cash Flow Conversion Efficiency for 111 Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of 111 Inc from 2016 to 2025. Review YI cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $214.56 Million | $119.14 Million | 0.555x | -19.61% |
| 2024-12-31 | $380.76 Million | $263.02 Million | 0.691x | +142.64% |
| 2023-12-31 | $276.10 Million | $-447.24 Million | -1.620x | -4435.40% |
| 2022-12-31 | $648.24 Million | $-23.15 Million | -0.036x | +95.28% |
| 2021-12-31 | $848.71 Million | $-641.94 Million | -0.756x | -761.87% |
| 2020-12-31 | $1.33 Billion | $-116.78 Million | -0.088x | +86.69% |
| 2019-12-31 | $773.92 Million | $-510.19 Million | -0.659x | -135.19% |
| 2018-12-31 | $1.22 Billion | $-343.02 Million | -0.280x | +56.27% |
| 2017-12-31 | $318.82 Million | $-204.37 Million | -0.641x | +5.07% |
| 2016-12-31 | $575.52 Million | $-388.65 Million | -0.675x | -- |
About 111 Inc
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education,… Read more